Aadi Bioscience, Inc.
NASDAQ:AADI
1.96 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||||
Net Income
| -65.765 | -60.513 | -110.09 | -3.478 | -23.271 | -10.397 | -21.401 | -16.984 | -17.07 | -0.029 | -0.027 | -0.027 | -0.022 | -0.022 | -0.02 | 0 |
Depreciation & Amortization
| 0.169 | 0.159 | 0.105 | 0.009 | 0.077 | 0.047 | 0.051 | 0.07 | 0.058 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax
| 7.023 | 0 | 72.375 | 0.153 | -2.477 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 11.954 | 9.643 | 2.106 | 0.139 | 0.106 | 3.432 | 0.649 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -3.404 | -1.82 | 12.245 | -10.506 | -1.893 | 1.11 | 1.536 | 0.516 | -1.342 | -0.028 | -0.031 | -0.027 | -0.066 | 0.004 | 0.001 | 0 |
Accounts Receivables
| -3.626 | -1.862 | 14.149 | -13.864 | -0.04 | 0 | 1.605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| -3.265 | -1.861 | 0 | 0 | 0.04 | 0 | -1.383 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -0.132 | 3.22 | 8.29 | 1.079 | -2.218 | 1.865 | 1.605 | 0.001 | 0.001 | -0.002 | -0.001 | 0.001 | 0.002 | 0.004 | 0.001 | 0 |
Other Working Capital
| 3.619 | -1.317 | -10.194 | 2.279 | 0.325 | -0.755 | -0.069 | 0.516 | -1.342 | -0.027 | -0.03 | -0.028 | -0.002 | -0.004 | -0.001 | 0 |
Other Non Cash Items
| -9.64 | 2.891 | 0.836 | 0.982 | 3.605 | 1.66 | -0.572 | 0.819 | 0.586 | 0.034 | 0.034 | 0.032 | 0.069 | -0.001 | -0.002 | 0 |
Operating Cash Flow
| -59.663 | -49.64 | -22.423 | -12.701 | -23.853 | -5.808 | -18.884 | -15.718 | -17.885 | -0.023 | -0.025 | -0.023 | -0.019 | -0.019 | -0.021 | -0.032 |
Investing Activities: | ||||||||||||||||
Investments In Property Plant And Equipment
| -3.972 | -0.444 | -0.046 | 0 | -0.237 | -0.038 | -0.009 | -0.113 | -0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net
| 0 | 132.442 | 25.199 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| -64.439 | -145.192 | 0 | 0 | 0 | 0 | -0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 151.617 | 12.75 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -0 | -132.442 | -4.501 | -0.019 | -0.237 | -0.038 | -0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| 83.206 | -132.886 | 25.153 | -0.019 | -0.237 | -0.038 | 0.041 | -0.113 | -0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Activities: | ||||||||||||||||
Debt Repayment
| 0 | 0 | 0 | -0.997 | -8.075 | 0 | -0.297 | -12.542 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0.326 | 72.5 | 155 | 9.744 | 0 | 51.698 | 40.284 | 0.019 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.005 | -0.006 | -0.005 | -0.004 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | -4.412 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.326 | 0.12 | -8.784 | -7.553 | 8.075 | -3.503 | -3.084 | 0.01 | 0.035 | 0.03 | 0.031 | 0.005 | 0.039 | 0.035 | 0.025 | 0 |
Financing Cash Flow
| 0.326 | 72.62 | 141.804 | 1.194 | 8.075 | 48.196 | 37.497 | 12.297 | 0.003 | 0.025 | 0.025 | 0.025 | 0.035 | 0.035 | 0.025 | 0 |
Other Information: | ||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.019 | 31.976 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 23.869 | -109.906 | 144.534 | -11.507 | -24.089 | 42.35 | 18.654 | 1.591 | 5.139 | 0.002 | 0 | -0.023 | 0.016 | 0.016 | 0.004 | -0.032 |
Cash At End Of Period
| 62.888 | 39.083 | 148.989 | 4.455 | 38.525 | 62.614 | 20.264 | 1.61 | 5.144 | 0.005 | 0.006 | 0.005 | 0.004 | 0.027 | 0.011 | -0.032 |